Intensive Multi-target Lipid Lowering and Progression of Coronary Atherosclerosis

被引：0
|
作者：
Hussein, Ayman A. [1 ]
Uno, Kiyoko [1 ]
Wolski, Kathy [1 ]
Tuzcu, Murat [1 ]
Nissen, Steven E. [1 ]
Nicholls, Stephen [1 ]
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Lipids; Coronary artery disease; Illumination;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13108
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Coronary and Extra-coronary Subclinical Atherosclerosis to Guide Lipid-Lowering Therapy
    Jelani K. Grant
    Carl E. Orringer
    Current Atherosclerosis Reports, 2023, 25 : 911 - 920
  • [42] Intensive Lipid-Lowering Therapy for Slowing Progression as Well as Inducing Regression of Atherosclerosis in Japanese Patients Subanalysis of the JART Study
    Yamazaki, Tsutomu
    Nohara, Ryuji
    Daida, Hiroyuki
    Hata, Mitsumasa
    Kaku, Kohei
    Kawamori, Ryuzo
    Kishimoto, Junji
    Kurabayashi, Masahiko
    Masuda, Izuru
    Sakuma, Ichiro
    Yokoi, Hiroyoshi
    Yoshida, Masayuki
    INTERNATIONAL HEART JOURNAL, 2013, 54 (01) : 33 - 39
  • [43] Intensive lipid-lowering therapy in patients with coronary heart disease
    Lauderdale, SA
    Sheehan, AH
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (02) : 329 - 334
  • [44] Allograft inflammatory factor-1, a multi-target regulator of atherosclerosis
    Zhang, Yujiao
    Tedgui, Alain
    Ait-Oufella, Hafid
    ATHEROSCLEROSIS, 2019, 289 : 179 - 180
  • [45] EFFECTS OF CHOLESTEROL-LOWERING ON THE PROGRESSION OF CORONARY ATHEROSCLEROSIS IN WOMEN - A CANADIAN CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL (CCAIT) SUBSTUDY
    WATERS, D
    HIGGINSON, L
    GLADSTONE, P
    BOCCUZZI, SJ
    COOK, T
    LESPERANCE, J
    CIRCULATION, 1995, 92 (09) : 2404 - 2410
  • [46] Effectiveness of hospital lipid-lowering protocol of intensive lipid-lowering therapy for patients with acute coronary syndrome
    Nakao, Sho
    Ishihara, Takayuki
    Tsujimura, Takuya
    Iida, Osamu
    Hata, Yosuke
    Toyoshima, Taku
    Higashino, Naoko
    Mano, Toshiaki
    JOURNAL OF CARDIOLOGY, 2022, 79 (03) : 391 - 399
  • [47] Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months -: A multicenter, randomized, double-blind trial
    Schmermund, A
    Achenbach, S
    Budde, T
    Buziashvili, Y
    Förster, A
    Friedrich, G
    Henein, M
    Kerkhoff, G
    Knollmann, F
    Kukharchuk, V
    Lahiri, A
    Leischik, R
    Moshage, W
    Schartl, M
    Siffert, W
    Steinhagen-Thiessen, E
    Sinitsyn, V
    Vogt, A
    Wiedeking, B
    Erbel, R
    CIRCULATION, 2006, 113 (03) : 427 - 437
  • [48] Effects of lipid lowering therapy on progression of coronary and carotid artery disease
    Ballantyne, CM
    Herd, JA
    Dunn, JK
    Jones, PH
    Farmer, JA
    Gotto, AM
    CURRENT OPINION IN LIPIDOLOGY, 1997, 8 (06) : 354 - 361
  • [49] CORONARY ENDOTHELIAL RESPONSES ARE IMPROVED WITH AGGRESSIVE LIPID-LOWERING THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS
    TREASURE, CB
    TALLEY, JD
    STILLABOWER, ME
    KLEIN, JL
    ZHANG, J
    BOCCUZZI, SJ
    CEDARHOLM, JC
    MANOUKIAN, SV
    WEINTRAUB, WS
    ALEXANDER, RW
    CIRCULATION, 1993, 88 (04) : 368 - 368
  • [50] Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy
    Ballantyne, CM
    Herd, JA
    Stein, EA
    Ferlic, LL
    Dunn, JK
    Gotto, AM
    Marian, AJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (05) : 1572 - 1578
12345